Influenza Vaccination Strategies in Patients with Hematologic Cancer

Victoria Hall; Olivia Smibert; Sheena G. Sullivan; Chhay Lim; Ian Barr; Heidi Peck; Paula Fuge-Larsen; Jessica Demajo; Emily Klimevski; Surekha Tennakoon; Natalie R Saunders; Trish Joyce; Ashley Whitechurch; Amit Khot; Mary Ann Anderson; Jason A. Trubiano; Michelle K. Yong; Leon J. Worth; Timothy Spelman; Monica A. Slavin; Benjamin W. Teh

doi:10.1056/nejmc2406750

Related publications

Article2025

Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial

Victoria Hall, Thi H. O. Nguyen, Olivia Smibert, Lilith F. Allen, Sheena G. Sullivan, Annette Fox, Louise Carolan, Adam K. Wheatley, Stephen J. Kent, Brad Gilbertson, Chhay Lim, Ian Barr, Heidi Peck, Paula Fuge-Larsen, Emily Klimevski, G. Surekha Tennakoon, Natalie R Saunders, Trish Joyce, Ashley Whitechurch, Amit Khot, Mary Ann Anderson, Jason A. Trubiano, Leon J. Worth, Michelle K. Yong, Monica A. Slavin, Katherine Kedzierska, Benjamin W. Teh

Article2019

Characterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: randomized controlled clinical trials conducted by the BIOVACSAFE consortium

January Weiner, David Lewis, Jeroen Maertzdorf, Hans‐Joachim Mollenkopf, Caroline L. Bodinham, Kat Pizzoferro, Catherine Linley, Aldona Greenwood, Alberto Mantovani, Barbara Bottazzi, Philippe Denoël, Geert Leroux‐Roels, Kent E. Kester, Ingileif Jónsdóttir, Robert A. van den Berg, Stefan H. E. Kaufmann, Giuseppe Del Giudice

Article2021

SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors

Flora Zagouri, Evangelos Terpos, Oraianthi Fiste, Michalis Liontos, Αlexandros Briasoulis, Ioanna Katsiana, Efi Skafida, Christos Markellos, Elena Kunadis, Αngeliki Andrikopoulou, Maria Kaparelou, Konstantinos Koutsoukos, Maria Gavriatopoulou, Efstathios Kastritis, Ioannis P. Trougakos, Meletios A Dimopoulos

Article2022

SARS‐CoV‐2 humoral responses following booster BNT162b2 vaccination in patients with B‐cell malignancies

Evangelos Terpos, Despina Fotiou, Vangelis Karalis, Ioannis Ntanasis‐Stathopoulos, Aimilia D. Sklirou, Maria Gavriatopoulou, Panagiotis Malandrakis, Vassiliki A. Iconomidou, Efstathios Kastritis, Ioannis P. Trougakos, Meletios A Dimopoulos

Article2022

Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS

Kate Stevens, Eleni Frangou, Jae Il Shin, Hans‐Joachim Anders, Annette Bruchfeld, Ulf Schönermarck, Thomas Häuser, Kerstin Westman, Gema Fernández‐Juárez, Jürgen Floege, Dimitrios Goumenos, Kültiğin Türkmen, Cees van Kooten, Stephen P. McAdoo, Vladimı́r Tesař, Mårten Segelmark, Duvuru Geetha, David Jayne, Andreas Kronbichler